Encoded Therapeutics
6 known investors
Encoded develops gene therapies for neurological disorders through an integrated platform approach. The company focuses on translating discoveries from research through clinical development and commercialization.
Investors · 6
In the news
- Encoded Therapeutics Announces $135 Million Series D Financing to Support First Clinical Trials in Saltitudelsv.com · 2020
- Encoded embeds $135m in series D round - Global Venturingglobalventuring.com · 2020
- Encoded Therapeutics Announces $135 Million Series D Financing to Support First Clinical Trials in SCN1A+ Dravet Syndrome and Advance Preclinical Pipeline of Gene Therapies for Debilitating Neurological Disorders – Encoded Therapeuticsencoded.com · 2020
- Encoded Therapeutics Raises $104M in Series C Financing - FinSMEsfinsmes.com · 2019
- Encoded Therapeutics Raises $104 Million to Advance Gene Therapy Program - Global Genesglobalgenes.org · 2019